Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report

Fig. 2

Trends of serum creatinine (top panel, dark-grey line), proteinuria/creatininuria (top panel, light-grey line), serum C3 (bottom panel, dark-blue line), serum C4 (bottom panel, light-blue line), anti-dsDNA titer (bottom panel, black line) from the date of kidney biopsy over time and through the different courses of Immunosuppressive therapies. I.v. steroid: three intravenous 500 mg methylprednisolone pulses; i.v. cyc: one intravenous 500 mg cyclophosphamide pulse; Fk: tacrolimus; prednisone: oral tapering prednisone

Back to article page